OSTUZZI, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 4.747
EU - Europa 4.216
AS - Asia 3.380
SA - Sud America 495
AF - Africa 137
OC - Oceania 19
Totale 12.994
Nazione #
US - Stati Uniti d'America 4.609
RU - Federazione Russa 1.921
SG - Singapore 1.446
CN - Cina 764
IT - Italia 598
GB - Regno Unito 554
BR - Brasile 392
VN - Vietnam 341
HK - Hong Kong 326
DE - Germania 211
SE - Svezia 188
FR - Francia 183
IE - Irlanda 183
FI - Finlandia 139
KR - Corea 105
BD - Bangladesh 100
CA - Canada 94
IN - India 65
ID - Indonesia 52
ES - Italia 39
UA - Ucraina 38
AR - Argentina 34
NL - Olanda 33
PL - Polonia 29
ZA - Sudafrica 29
IQ - Iraq 27
NG - Nigeria 26
AT - Austria 25
MX - Messico 25
TG - Togo 23
BJ - Benin 22
JP - Giappone 20
VE - Venezuela 18
TR - Turchia 16
BE - Belgio 15
PK - Pakistan 15
CO - Colombia 13
AU - Australia 12
SA - Arabia Saudita 12
EC - Ecuador 10
PH - Filippine 10
UZ - Uzbekistan 10
MA - Marocco 9
MY - Malesia 9
CL - Cile 8
IL - Israele 8
KE - Kenya 8
LT - Lituania 8
TW - Taiwan 8
UY - Uruguay 8
CZ - Repubblica Ceca 7
DK - Danimarca 7
NZ - Nuova Zelanda 7
NP - Nepal 6
PE - Perù 6
ET - Etiopia 5
GR - Grecia 5
JM - Giamaica 5
AE - Emirati Arabi Uniti 4
JO - Giordania 4
LB - Libano 4
PS - Palestinian Territory 4
PY - Paraguay 4
AZ - Azerbaigian 3
BG - Bulgaria 3
EG - Egitto 3
HN - Honduras 3
HU - Ungheria 3
KZ - Kazakistan 3
MD - Moldavia 3
NO - Norvegia 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
AO - Angola 2
BO - Bolivia 2
BW - Botswana 2
CM - Camerun 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EE - Estonia 2
IR - Iran 2
IS - Islanda 2
KG - Kirghizistan 2
KW - Kuwait 2
LK - Sri Lanka 2
LV - Lettonia 2
OM - Oman 2
PA - Panama 2
RS - Serbia 2
TH - Thailandia 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CU - Cuba 1
Totale 12.982
Città #
Singapore 750
Moscow 640
Ashburn 631
San Jose 549
Dallas 462
Chandler 411
Southend 397
Hong Kong 316
Verona 263
Dublin 167
Beijing 159
The Dalles 152
New York 148
Houston 125
Jacksonville 115
Los Angeles 115
Council Bluffs 103
Ho Chi Minh City 97
Woodbridge 73
Lawrence 64
Princeton 64
Wilmington 64
Ann Arbor 62
Munich 59
Santa Clara 58
Helsinki 57
Hanoi 56
Buffalo 51
London 46
Dong Ket 41
Jakarta 41
Redondo Beach 41
Columbus 39
Seattle 39
São Paulo 37
Boardman 35
Chicago 32
Jinan 32
Lappeenranta 31
Milan 29
Toronto 29
Kent 27
Nanjing 27
Abuja 26
Sindelfingen 26
Lomé 23
Shenyang 23
Warsaw 23
Washington 23
Boston 22
Cotonou 22
Rome 22
Frankfurt am Main 21
Montreal 21
Redwood City 21
Tianjin 21
Turku 21
Zhengzhou 21
Atlanta 20
Nuremberg 20
Dearborn 19
Phoenix 19
Amsterdam 18
Denver 18
Tokyo 18
Johannesburg 17
Manchester 17
Orem 16
Poplar 15
San Francisco 15
Vienna 15
Brooklyn 14
Chennai 14
Guangzhou 14
Hebei 14
Redmond 14
Brussels 13
Haikou 13
Nanchang 13
Stockholm 13
Haiphong 12
Mexico City 12
Belo Horizonte 11
Da Nang 11
Düsseldorf 11
Hangzhou 11
Jiaxing 11
Ningbo 11
Norwalk 11
Rio de Janeiro 11
Baghdad 10
Madrid 10
Taizhou 10
Padova 9
Roverbella 9
Tashkent 9
Buenos Aires 8
Caracas 8
Falkenstein 8
Hải Dương 8
Totale 7.620
Nome #
Beyond pain: can antidepressants improve depressive symptoms and quality of life in patients with neuropathic pain? A systematic review and meta-analysis 478
A network meta-analysis of psychosocial interventions for refugees and asylum seekers with PTSD 230
Adverse effects of antipsychotic drugs: survey of doctors' versus patients' perspective. 226
Common mental disorders in asylum seekers and refugees: umbrella review of prevalence and intervention studies 223
Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval 200
Efficacy and acceptability of antidepressants in patients with ischemic heart disease: systematic review and meta-analysis 193
Making the use of psychotropic drugs more rational through the development of GRADE recommendations in specialist mental healthcare 192
Antipsychotic drug exposure and risk of myocardial infarction 189
Maintenance treatment with long-acting injectable antipsychotics for people with nonaffective psychoses: a network meta-analysis 188
Combinations of QTc-prolonging drugs: towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive nature 187
Continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: a systematic review and network meta-analysis 186
Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy 185
Comparative efficacy and acceptability of psychosocial interventions for PTSD, depression, and anxiety in asylum seekers, refugees, and other migrant populations: a systematic review and network meta-analysis of randomised controlled studies 184
Does formulation matter? A systematic review and meta-analysis of oral versus long-acting antipsychotic studies 182
Efficacy and acceptability of psychosocial interventions in asylum seekers and refugees: systematic review and meta-analysis 177
Antidepressants for the treatment of depression in people with cancer 173
Comparing long-acting antipsychotic discontinuation rates under ordinary clinical circumstances: a survival analysis from an observational, pragmatic study 173
Effectiveness and cost-effectiveness of Self-Help Plus (SH+) for preventing mental disorders in refugees and asylum seekers in Europe and Turkey: study protocols for two randomised controlled trials 169
First-generation antipsychotics and QTc: any role for mediating variables? 168
Antipsychotic combinations in schizophrenia 164
Implementation of treatment guidelines for specialist mental health care 162
Antipsychotic drug exposure and risk of fracture: a systematic review and meta-analysis of observational studies 161
Effectiveness of Self-Help Plus in preventing mental disorders in refugees and asylum seekers in Western Europe: a multinational randomized controlled trial 161
Treatment of locally advanced rectal cancer in the era of total neoadjuvant therapy: a systematic review and network meta-analysis 160
Can we identify the active ingredients of behaviour change interventions for coronary heart disease patients? A systematic review and meta-analysis 153
Can a digital medicine system improve adherence to antipsychotic treatment? 153
Antipsychotic use and risk of life-threatening medical events: umbrella review of observational studies 153
Beneficial and harmful consequences of prepartum and postpartum antidepressant exposure 152
Long-acting antipsychotics: patient’s features and prescribing attitudes in Italy. Findings from the cross-sectional phase of an observational, longitudinal, multicenter study. 151
Prevalence and correlates of QTc prolongation in Italian psychiatric care: cross-sectional multicentre study 150
Oral and long-acting antipsychotics for relapse prevention in schizophrenia-spectrum disorders: a network meta-analysis of 92 randomized trials including 22,645 participants 148
Umbrella systematic review and meta-analysis: physical activity as an effective therapeutic strategy for improving psychosocial outcomes in children and adolescents 146
Effectiveness of a stepped-care programme of WHO psychological interventions in migrant populations resettled in Italy: study protocol for the RESPOND randomized controlled trial 146
Tolerability and efficacy of vortioxetine versus SSRIs in elderly with major depression. Study protocol of the VESPA study: a pragmatic, multicentre, open-label, parallel-group, superiority, randomized trial 145
Efficacy of psychosocial interventions for mental health outcomes in low-income and middle-income countries: an umbrella review 141
Prevalence and Correlates of Psychological Distress and Psychiatric Disorders in Asylum Seekers and Refugees Resettled in an Italian Catchment Area 138
Mapping the evidence on pharmacological interventions for non-affective psychosis in humanitarian non-specialised settings: a UNHCR clinical guidance 137
Candidate diagnostic biomarkers for neurodevelopmental disorders in children and adolescents: a systematic review 136
Autism spectrum disorders: weighing the risk of SSRI exposure in pregnancy 136
Cost-effectiveness of the Self-Help Plus Intervention for Adult Syrian Refugees Hosted in Turkey 136
Reasons for initiating long-acting antipsychotics in psychiatric practice: findings from the STAR Network Depot Study 135
Characterising alexithymia in individuals with functional motor disorders: a cross-sectional analysis of the Italian Registry of Functional Motor Disorders 134
Calling for policy actions to increase access to long-acting antipsychotics in low-income and middle-income countries 134
Antidepressants for the treatment of depression in people with cancer 132
CBT treatment delivery formats for panic disorder: a systematic review and network meta-analysis of randomised controlled trials 131
Public health psychopharmacology: a new research discipline comes of age? 131
Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations 129
Early pharmacological interventions for universal prevention of post-traumatic stress disorder (PTSD) 128
An umbrella review of candidate predictors of response, remission, recovery, and relapse across mental disorders 124
Clinical trajectories of individuals with severe mental illness continuing and discontinuing long-acting antipsychotics: a one-year mirror-image analysis from the STAR Network Depot study 124
New EMA report on paliperidone 3-month injections: taking clinical and policy decisions without an adequate evidence base 124
Esketamine for treatment resistant depression: a trick of smoke and mirrors? 124
Tolerability of vortioxetine compared to selective serotonin reuptake inhibitors in older adults with major depressive disorder (VESPA): a randomised, assessor-blinded and statistician-blinded, multicentre, superiority trial 122
Effectiveness of a stepped-care programme of WHO psychological interventions in a population of migrants: results from the RESPOND randomized controlled trial 122
Efficacy and acceptability of long-acting antipsychotics in acutely ill individuals with schizophrenia-spectrum disorders: A systematic review and network meta-analysis 122
Effects of COVID-19 pandemic on psychiatric and psychological consultation-liaison contacts in a general hospital in North-East of Italy: a retrospective study 122
Comparing 1-year effectiveness and acceptability of once-monthly paliperidone palmitate and aripiprazole monohydrate for schizophrenia spectrum disorders: Findings from the STAR Network Depot Study 122
Effectiveness of a WHO self-help psychological intervention for preventing mental disorders among Syrian refugees in Turkey: a randomized controlled trial 121
Comparative efficacy and acceptability of psychotherapies for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials 120
Long-term effectiveness of Self-Help Plus in refugees and asylum seekers resettled in Western Europe: 12-month outcomes of a randomised controlled trial 120
Withdrawal syndrome following discontinuation of 28 antidepressants: pharmacovigilance analysis of 31,688 reports from the WHO spontaneous reporting database 115
Efficacy of interventions to reduce coercive treatment in mental health services: umbrella review of randomised evidence 115
Psychotherapies for Generalized Anxiety Disorder in Adults: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials 114
Medicine-based evidence: the case of antidepressants in patients with coronary artery disease 110
SSRI plus supportive care more effective than supportive care alone for mild to moderate depression 106
Efficacy and acceptability of antidepressants on the continuum of depressive experiences in patients with cancer: Systematic review and meta-analysis 106
Comparative effectiveness of long-acting antipsychotics: issues and challenges from a pragmatic randomised study 105
Association between adverse childhood experiences and suicidal behavior in schizophrenia spectrum disorders: A systematic review and meta-analysis 103
Efficacy and tolerability of antidepressants in individuals suffering from physical conditions and depressive disorders: network meta-analysis 102
Vortioxetine for depression in adults 101
Introduction and methods of the evidence-based guidelines for the diagnosis and management of autism spectrum disorder by the Italian National Institute of Health 98
Association between sleep disturbances and suicidal behavior in adolescents: a systematic review and meta-analysis 97
Esketamine clinical trials: reply to Maju et al 97
Clinical correlates of paliperidone palmitate and aripiprazole monohydrate prescription for subjects with schizophrenia-spectrum disorders: findings from the STAR Network Depot Study 95
Association between adverse childhood experiences and suicidal behavior in affective disorders: A systematic review and meta-analysis 94
Crossroads of methodological choices in research synthesis: insights from two network meta-analyses on preventing relapse in schizophrenia 93
Efficacy and safety of long-acting injectable versus oral antipsychotics in the treatment of patients with early-phase schizophrenia-spectrum disorders: a systematic review and meta-analysis 93
Effect of long-acting injectable antipsychotics on 1-year hospitalization in bipolar disorder: a mirror-image study 92
Early pharmacological interventions for prevention of post-traumatic stress disorder (PTSD) in individuals experiencing acute traumatic stress symptoms 92
Regulatory meta-analyses for the evaluation of psychotropic medicines 90
The role of attitudes toward medication and treatment adherence in the clinical response to LAIs: findings from the STAR Network Depot Study 89
Risk factors for mental disorder development in asylum seekers and refugees resettled in Western Europe and Turkey: Participant-level analysis of two large prevention studies 88
Efficacy and Tolerability of Vortioxetine Versus Selective Serotonin Reuptake Inhibitors for Late-Life Depression: A Post-hoc Analysis of the VESPA Study 85
Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches 85
Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations 82
Are sleep disturbances a risk factor for suicidal behavior in the first episode of psychosis? Evidence from a systematic review 80
Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database 79
Off-label long acting injectable antipsychotics in real-world clinical practice: a cross-sectional analysis of prescriptive patterns from the STAR Network DEPOT study 78
Ground-breaking change to the mental health section of the WHO Model List of Essential Medicines: implications for low- and middle-income countries 76
Updating the WHO Model Lists of Essential Medicines to promote global access to the most cost-effective and safe medicines for mental disorders 73
Which psychotherapy is effective in panic disorder? And which delivery formats are supported by the evidence? Study protocol for two systematic reviews and network meta-analyses 71
Comment on: Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials 70
Mapping the selection, availability, price and affordability of essential medicines for mental health conditions at a global level 67
Have the COVID-19 outbreak and related restrictions affected the right to mental health of people with severe mental health conditions? 66
Poor implementation of the EU clinical trial regulation is a major threat for pragmatic trials in European countries 66
Preventing relapse in schizophrenia needs better evidence 64
Factors associated with medication adherence to long-acting injectable antipsychotics: results from the STAR Network Depot Study 59
Combining randomised and observational evidence in schizophrenia: how real is the real world? 57
Expanding access to long-acting antipsychotics in low-income and middle-income countries 54
The WHO Model List of Essential Medicines for Children needs its own identity: the case of psychotropic medicines 54
Totale 13.014
Categoria #
all - tutte 47.302
article - articoli 46.915
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 387
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.604


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202181 0 0 0 0 0 0 0 0 0 0 0 81
2021/2022494 21 76 2 45 66 9 17 35 24 14 52 133
2022/20231.291 73 133 101 202 111 268 33 100 167 30 43 30
2023/2024909 58 69 65 87 109 143 42 67 19 47 117 86
2024/20252.308 108 97 119 377 136 117 93 115 345 227 192 382
2025/20266.715 453 255 532 1.090 1.715 434 640 382 499 377 168 170
Totale 13.170